Richard L. Casey

Chief Executive Officer at Neuraltus Pharmaceuticals, Inc.

Richard L. Casey

Richard L. Casey

Chief Executive Officer at Neuraltus Pharmaceuticals, Inc.

Overview
Career Highlights

Neuraltus Pharmaceuticals, Inc.
Cellgate, Inc.
Scios, Inc.

RelSci Relationships

356

Number of Boards

3

Relationships
RelSci Relationships are individuals Richard L. Casey likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at ZP Opco, Inc.

Relationship likelihood: Strong

Strategic Advisor at VantagePoint Management, Inc.

Relationship likelihood: Strong

Director at ProteinSimple

Relationship likelihood: Strong

Former Global Assurance Leader at PricewaterhouseCoopers LLP

Relationship likelihood: Strong

Founder at Neuraltus Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Business Officer at Cyteir Therapeutics, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Ardelyx, Inc.

Relationship likelihood: Strong

Founder at Quaker Partners Management LP

Relationship likelihood: Strong

Vice President-Research & Development at Aridis Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at CanFel Therapeutics

Relationship likelihood: Strong

Paths to Richard L. Casey
Potential Connections via
Relationship Science
You
Richard L. Casey
Chief Executive Officer at Neuraltus Pharmaceuticals, Inc.
Education
B.S Chemistry

Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. Stanford was founded in 1885 by Leland and Jane Stanford in memory of their only child, Leland Stanford Jr., who had died of typhoid fever at age 15 the previous year. Stanford is generally ranked among the best universities in the world by academic publications. It is also one of the top fundraising institutions in the country, becoming the first school to raise more than a billion dollars in a year.

MBA Unknown

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History
Chief Executive Officer
2013 - Current

Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA.

Chairman & Chief Executive Officer
Prior - 2009

Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA.

Chairman & Chief Executive Officer
Prior

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

Transactions
Details Hidden

Neuraltus Pharmaceuticals, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard L. Casey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard L. Casey's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard L. Casey.